Ganglioside GM2 activator (GM2A) is as a novel pro-survival p53 target in hepatocellular carcinoma - Holzer, K; Drucker, E; Waldburger, N; Eiteneuer, E; Breuhahn, K; Ori, A; Schirmacher, P; Singer, S (Zeitschrift für Gastroenterologie, 2018)